STATE REFERRAL LETTER
Diabetes Corporation of AmericaFDA STATE_REFERRAL_LETTER - Diabetes Corporation of America - June 10, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This STATE REFERRAL LETTER record concerns Diabetes Corporation of America, with an inspection on June 10, 2017, issued by the Office of Pharmaceutical Quality, covering drugs.
Open in Dashboard
ID · 4f7a853b-bafc-49f5-b6e1-8ef04bd3956f
Violation Codes3
21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A(a)
Full citation text and observation details available on the Dashboard.